Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Postoperative Nausea and Vomiting 1 Postoperative Complications 1 Pancreatitis 1 Pancreatic Neoplasms 1 Pancreatic Diseases 1 Pain, Postoperative 1 Lung Neoplasms 1 Genital Diseases, Female 1

Interventions

niraparib 2 anlotinib 2 Robotic Surgical Procedures 2 Paclitaxel 2 Carboplatin 2 Bevacizumab 2 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2 temsirolimus 1 olaparib 1 carboprost tromethamine 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Trabectedin 1 Preoperative Care 1 Pregnancy Tests 1 Postoperative Care 1 Ocoxin 1 Laparoscopy 1 Intraoperative Care 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Human Papillomavirus DNA Tests 1 GX-188 vaccine 1 Filgrastim 1 Diffusion 1 Dexamethasone 1 Colposcopy 1 CP protocol 1 Biopsy 1 Acetic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Genital Diseases, Female × Postoperative Care × Clear all

NCT03347409 2020-02-07

ERASGYNBS001

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase NA Completed

Genital Diseases, Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡